[1] GOTHENBURG UNIV, DEPT CLIN PHARMACOL, S-41124 GOTHENBURG, SWEDEN
来源:
PHARMACOLOGY & TOXICOLOGY
|
1994年
/
74卷
/
4-5期
关键词:
D O I:
10.1111/j.1600-0773.1994.tb01098.x
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Since the discovery of neuropeptide Y which is co-stored and co-operate with noradrenaline (NA) in sympathetic nerve fibers, several scientific groups have searched for structures with neuropeptide Y antagonistic properties. Research has mainly focused on various peptide fragments which originate from or are related to the neuropeptide Y sequence. Some non-peptide antagonists have been proposed but they are mostly of low potency and non-selective. Our recent observations that alpha-trinositol (D-myo-inositol 1.2.6-trisphosphate) is an inhibitor of neuropeptide Y effects will hopefully lead to the development of useful non-peptide neuropeptide Y inhibitors. As a novel approach the highly selective approach of down-regulating neuropeptide Y receptors with antisense oligodeoxynucleotides is also discussed. Neuropeptide Y antagonistic agents would help us to understand the physiological role of neuropeptide Y and may serve as useful medication in circulation disorders.